Clinical Trial Update: Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

View source ↗

Summary

This observational study investigates cardiac arrhythmias in patients treated with BTK inhibitors or venetoclax in chronic lymphocytic leukemia, Waldenström mac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Mantle Cell Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• Acalabrutinib (acalabrutinib)
• Ibrutinib (ibrutinib)
• Venetoclax (venetoclax)
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Chronic Lymphocytic Leukemia (CLL), Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia | Status: RECRUITING